LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Sarcoidosis, An Issue of Clinics in Chest Medicine
- 1st Edition, Volume 45-1 - January 29, 2024
- Editors: Robert Phillip Baughman, Elyse E. Lower, Marc A. Judson
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 1 8 2 3 2 - 7
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 8 2 3 3 - 4
In this issue of Clinics in Chest Medicine, guest editors Drs. Robert P. Baughman, Elyse E. Lower, and Marc A. Judson bring their considerable expertise to the topic of Sarcoi… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteIn this issue of Clinics in Chest Medicine, guest editors Drs. Robert P. Baughman, Elyse E. Lower, and Marc A. Judson bring their considerable expertise to the topic of Sarcoidosis. Top experts in the field discuss the role of bronchoscopy in diagnosis of sarcoidosis; monitoring pulmonary sarcoidosis; ocular sarcoidosis; biomarkers in sarcoidosis; cutaneous sarcoidosis; neurologic sarcoidosis; and more.
- Contains 15 relevant, practice-oriented topics including sarcoidosis-associated pulmonary hypertension; predictors of mortality from sarcoidosis; hematologic manifestations of sarcoidosis; quality of life; anti-inflammatory therapy for sarcoidosis; and more.
- Provides in-depth clinical reviews on sarcoidosis, offering actionable insights for clinical practice.
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Chest Medicine
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Forthcoming Issues
- Preface
- Epidemiology of Sarcoidosis
- Key points
- Introduction
- Presentation
- Geography
- Age
- Sex
- Race and ethnicity
- Modifiable risk factors
- Infection
- Summary
- Disclosure
- Funding
- Diagnosis of Pulmonary Sarcoidosis
- Key points
- Imaging tests
- Biomarkers in the diagnosis of sarcoidosis
- Diagnostic procedures
- Summary
- Clinics care points
- Disclosure
- Role of Bronchoscopy in Diagnosis of Sarcoidosis
- Key points
- Introduction
- Standard bronchoscopic techniques
- Advanced bronchoscopic techniques
- Summary
- Disclosure/ Conflict of interest
- Funding
- Biomarkers in Sarcoidosis: Beginning of a New Era?
- Key points
- Introduction
- Serum biomarkers
- Imaging biomarkers
- Future biomarkers
- Summary
- Clinics care points
- Monitoring of Sarcoidosis
- Key points
- Introduction
- Key considerations in the nature of monitoring protocols in pulmonary sarcoidosis
- The need for multidimensional monitoring
- Monitoring quality of life
- Optimal integration of the multidimensional evaluation of interstitial lung disease progression
- Frequency of monitoring in pulmonary sarcoidosis
- Comorbidities and routine monitoring
- Other considerations
- Summary
- Clinics care points
- Conflict of interest
- Funding
- Ocular Sarcoidosis
- Key points
- Epidemiology
- Summary
- Clinics care points
- Disclosure
- Cutaneous Sarcoidosis
- Key points
- Introduction
- Burden of cutaneous disease
- Clinical presentation
- Summary
- Clinics care points
- Funding sources and conflict of interest
- Neurosarcoidosis and Neurologic Complications of Sarcoidosis Treatment
- Key points
- Introduction
- Clinical presentation
- Treatment
- Neurologic adverse effects of pharmacologic sarcoidosis treatment
- Summary
- Clinics care points
- Disclosure
- Cardiac Sarcoidosis
- Key points
- Introduction
- History
- Definitions
- Epidemiology
- Evaluation
- Therapeutic options
- Clinics care points
- Disclosure
- Hematologic and Oncologic Aspects of Sarcoidosis: Some of the Least Studied but Most Common Dilemmas
- Key points
- Introduction
- Cytopenias and sarcoidosis
- Proposed mechanism of action—the spleen
- Proposed mechanism of action: bone marrow involvement
- Proposed mechanism of action and immune dysregulation: platelets and red blood cells
- Immune dysregulation and white blood cells
- The complex interaction of sarcoidosis and malignancy
- Summary
- Clinics care points
- Anti-inflammatory Therapy for Sarcoidosis
- Key points
- Introduction
- Indications for anti-inflammatory therapy in sarcoidosis
- The inflammatory cascade and immunopathogenic pathways in sarcoidosis
- Stepwise anti-inflammatory medications in sarcoidosis
- Approach to treatment in sarcoidosis
- Treatment duration, monitoring, and evaluation of failed response to therapy
- New and emerging therapeutic agents
- Summary
- Disclosures and conflict of interest statement
- Health-Related Quality of Life Assessment in Sarcoidosis
- Key points
- Introduction
- The definition and importance of health-related quality of life
- The measurement of health-related quality of life in sarcoidosis
- Specific health quality of life measurements used in sarcoidosis
- Factors that influence health-related quality of life in patients with sarcoidosis
- Specific health-related quality of life issues in sarcoidosis
- Interventions to improve health-related quality of life in sarcoidosis
- Summary
- Clinics care points
- Disclosure
- Predictors of Mortality in Sarcoidosis
- Key points
- Introduction
- Summary
- Clinics care points
- Sarcoidosis-Associated Pulmonary Hypertension
- Key points
- Introduction
- Summary
- Clinics care points
- Conflict of interest statement
- Fibrotic Pulmonary Sarcoidosis
- Key points
- Introduction
- Pathology and pathogenesis of fibrotic pulmonary sarcoidosis
- Risk factors and clinical presentation of fibrotic pulmonary sarcoidosis
- Imaging of fibrotic pulmonary sarcoidosis
- Lung function in fibrotic pulmonary sarcoidosis
- Evaluation of persistent granulomatous inflammation in fibrotic pulmonary sarcoidosis
- Fibrotic pulmonary sarcoidosis with usual interstitial pneumonia-like pattern
- Complications during the course of fibrotic pulmonary sarcoidosis
- Fibrotic pulmonary sarcoidosis and the concept of progressive pulmonary fibrosis
- Mortality of fibrotic pulmonary sarcoidosis and prognostic stratification
- Management of fibrotic pulmonary sarcoidosis
- Future challenges and perspectives
- Clinics care points
- No. of pages: 240
- Language: English
- Edition: 1
- Volume: 45-1
- Published: January 29, 2024
- Imprint: Elsevier
- Hardback ISBN: 9780443182327
- eBook ISBN: 9780443182334
RB
Robert Phillip Baughman
Dr. Baughman is Professor of Medicine at the University of Cincinnati. After completing undergraduate training at Yale University, he received his medical degree from Case Western Reserve School of Medicine. He joined the Internal Medicine staff at the University of Cincinnati after completing both an Internal Medicine residency and fellowship training in pulmonary diseases at the University of Cincinnati. His major research interests include: the treatment of sarcoidosis and bronchoalveolar lavage. Along with his long time collaborator Dr. Elyse Lower, he has developed several novel treatments for sarcoidosis, including methotrexate, thalidomide, leflunomide, and infliximab. Current studies include treatments for sarcoidosis associated fatigue and pulmonary hypertension due to sarcoidosis. He is on the editorial board of multiple subspecialty journals, and his publications include over 300 original papers mostly regarding various aspects of sarcoidosis and over 70 review articles and/or book chapters. He has edited several books on sarcoidosis and other interstitial lung diseases. He is on the editorial board of several journals, including American Journal of Respiratory and Critical Care Medicine and Chest. In addition, Dr. Baughman is the recent editor of books on sarcoidosis, interstitial lung disease, and ventilator associated pneumonia. He has been an active member of World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) since its inception and is President Emeritus.
Affiliations and expertise
Professor of Medicine, Department of Medicine, University of Cincinnati Medical Center, Cincinnati, OH, USAEL
Elyse E. Lower
Affiliations and expertise
Department of Medicine, University of Cincinnati Medical Center,MJ
Marc A. Judson
Affiliations and expertise
Division of Pulmonary and Critical Care Medicine, Albany Medical College,